Veery Capital LLC Lowers Stock Position in DexCom, Inc. (NASDAQ:DXCM)

Veery Capital LLC lowered its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 6.1% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 4,008 shares of the medical device company’s stock after selling 260 shares during the period. Veery Capital LLC’s holdings in DexCom were worth $515,000 as of its most recent SEC filing. […]

Related Keywords

United States ,Piper Sandler ,Steven Robert Pacelli ,Raymond James ,Morgan Stanley ,Everhart Financial Group Inc ,Securities Exchange Commission ,Patton Fund Management Inc ,Dexcom Company Profile ,Hb Wealth Management ,Crescent Grove Advisors ,Dexcom Inc ,Veery Capital ,Perfromance Wealth Partners ,Nasdaq ,Free Report ,Grove Advisors ,Wealth Partners ,Financial Group ,Patton Fund Management ,Director Steven Robert Pacelli ,Exchange Commission ,Get Free Report ,Dexcom Share ,Dexcom Real Time ,Visit Holdingschannel ,Dexcom Daily ,Dexcom ,Nasdaq Dxcm ,Dxcm ,Medical ,25213110 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,